Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest announcement is out from Dr. Martens Plc ( (GB:DOCS) ).
Dr. Martens PLC announced its trading results for the third quarter of 2024, highlighting a 3% increase in group revenue on a constant currency basis, driven by positive growth in the Americas and APAC regions. The company maintained its FY25 outlook and is focused on sustainable and profitable growth, particularly in the US market, while managing costs and inventory levels.
More about Dr. Martens Plc
Dr. Martens is a renowned British brand established in 1960, known for its robust, durable boots originally designed for workers. The brand has been embraced by various youth subcultures and musical movements, symbolizing empowerment and individuality. Listed on the London Stock Exchange, Dr. Martens is part of the FTSE 250 index.
YTD Price Performance: 0.35%
Average Trading Volume: 1,911,978
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £698.3M
See more insights into DOCS stock on TipRanks’ Stock Analysis page.
